Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (3) , 590-598
- https://doi.org/10.1111/j.1538-7836.2007.02386.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Neovascularization in Human AtherosclerosisCirculation, 2006
- Angiogenesis as a therapeutic targetNature, 2005
- The VIVA TrialCirculation, 2003
- A target‐mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humansClinical Pharmacology & Therapeutics, 2002
- Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery diseaseAmerican Heart Journal, 2001
- Mechanisms of angiogenesis and arteriogenesisNature Medicine, 2000
- Angiogenesis and arteriogenesis – not yet for prescriptionClinical Research in Cardiology, 2000
- Impaired Collateral Vessel Development Associated With Reduced Expression of Vascular Endothelial Growth Factor in ApoE −/− MiceCirculation, 1999
- Comparison of VEGF Delivery Techniques on Collateral-Dependent Microvascular ReactivityMicrovascular Research, 1998
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.Journal of Clinical Investigation, 1994